OALib Journal期刊
ISSN: 2333-9721
费用:99美元
|
|
|
重组人乙酰胆碱酯酶的表达及其抑制剂的筛选
, PP. 50-54
Keywords: 重组,乙酰胆碱酯酶,hek293细胞,酶活性,抑制剂,筛选,多奈哌齐
Abstract:
本研究旨在表达重组人乙酰胆碱酯酶(recombinanthumanacetylcholinesterase,rhache)并应用于乙酰胆碱酯酶抑制剂筛选研究。利用质粒pcmv-ache瞬时转染hek293细胞,分泌表达rhache。考察rhache的酶活性:以碘化硫代乙酰胆碱(atch)为底物进行酶底物动力学研究获得rhache的米氏常数km,以多奈哌齐(donepezil)为抑制剂进行酶抑制作用动力学研究获得ki、ki’等参数。利用rhache测定新化合物的ic50值,评价新化合物的抑制活性,同时将研究结果与文献报道的提取大鼠ache的抑制活性进行比较。结果测得rhache的km为151.9μmol·l-1,多奈哌齐对rhache的抑制作用为竞争性和非竞争性结合的混合类型(ki=16.03nmol·l-1,ki’=18.36nmol·l-1),rhache可应用于抑制剂筛选研究。
References
[1] | zlokovicbv.neurovascularpathwaystoneurodegenerationinalzheimer'sdiseaseandotherdisorders[j].natrevneurosci,2011,12:723-738.
|
[2] | yangwc,sunq,yunx,etal.designofacetylcholinesteraseinhibitorforalzheimer'sdiseasetherapy:frommulti-bindingsiteinhibitorstomulti-targetdirectedligands[j].actapharmsin(药学学报),2012,47:313-321.
|
[3] | fischerm,ittaha,goreckym,etal.recombinanthumanacetylcholinesteraseexpressedinescherichiacoli:refolding,purificationandcharacterization[j].biotechnolapplbiochem,1997,21:295-311.
|
[4] | rachinsktl,camps,liy,etal.molecularcloningofmouseacetylcholinesterase:tissuedistributionofalternativelysplicedmrnaspecies[j].neuron,1990,5:317-327.
|
[5] | legayc,bons,vernierp,etal.cloningandexpressionofaratacetylcholinesterasesubunit:generationofmultiplemolecularformsandcomplementaritywithatorpedocollagenicsubunit[j].jneurochem,1993,60:337-346.
|
[6] | heimj,shmidt-dannertc,atomih,etal.functionalexpressionofamammalianacetylcholinesteraseinpichiapastoris:comparisontoacetylcholinesterase,expressedandreconstitutedfromescherichiacoli[j].biochimbiophysacta,1997,1396:306-319.
|
[7] | chitlarut,kronmanc,velanb,etal.effectofhumanacetylcholinesterasesubunitassemblyonitscirculatoryresidence[j].biochemj,2001,354:613-625.
|
[8] | sreekrishnak,brankamprg,kroppke,etal.strategiesforoptimalsynthesisandsecretionofheterologousproteinsinthemethylotrophicyeastpichiapastoris[j].gene,1997,190:55-62.
|
[9] | saxenaa,fedorkojm,vinayakacr,etal.aromaticamino-acidresiduesattheactiveandperipheralanionicsitescontrolthebindingofe2020(aricept®)tocholinesterases[j].eurjbiochem,2003,270:4447-4458.
|
[10] | jahnkeu.therapeuticapproachesforalzheimer'sdisease[j].drugs,2008,11:4-6.
|
[11] | darreh-shorit,soininenh.effectsofcholinesteraseinhibitorsontheactivitiesandproteinlevelsofcholinesterasesinthecerebrospinalfluidofpatientswithalzheimer'sdisease:areviewofrecentclinicalstudies[j].curralzheimerres,2010,7:67-73.
|
[12] | zhangyd,caiyn,zhangq,etal.inhibitoryeffectoficariinonacetylcholinesterase[j].actapharmsin(药学学报),2012,47:1141-1146.
|
[13] | zhuy,tongxy,zhaoy,etal.constructionofthepharmacophoremodelofacetylcholinesteraseinhibitor[j].actapharmsin(药学学报),2008,43:267-276.
|
[14] | sheny,shengr,zhangj,etal.2-phenoxy-indan-1-onederivativesasacetylcholinesteraseinhibitors:astudyontheimportanceofmodificationsatthesidechainontheactivity[j].bioorgmedchem,2008,16:7646-7653.
|
[15] | velanb,kronmanc,grosfeldh,etal.recombinanthumanacetylcholinesteraseissecretedfromtransientlytransfected293cellsasasolubleglobularenzyme[j].cellmolneurobiol,1991,11:143-156.
|
[16] | chenhl,liwj.molecularenzymology(分子酶学)[m].beijing:people'smedicalpublishinghouse,1983:269-270.
|
[17] | taylorp.thecholinesterases[j].jbiolchem,1991,266:4025-4028.
|
[18] | maxy,tanjh,weidz,etal.high-levelsecretionandpurificationofrecombinantacetylcholinesterasefromhumancerebraltissueinp.pastorisandidentificationbychromogenicreaction[j].applmicrobiolbiotechnol,2006,72:316-322.
|
[19] | simons,massouliej.cloningandexpressionofacetylcholinesterasefromelectrophorussplicingpatternofthe3'exonsinvivoandintransfectedmammaliancells[j].jbiolchem,1997,272:33045-33055.
|
[20] | chitlarut,kronmanc,velanb,etal.overloadingandremovalofn-glycosylationtargetsonhumanacetylcholinesterase:effectsonglycancompositionandcirculatoryresidencetime[j].biochemj,2002,363:619-631.
|
Full-Text
|
|
Contact Us
service@oalib.com QQ:3279437679 
WhatsApp +8615387084133
|
|